|
|
Volumn 20, Issue 1, 2006, Pages 3-4
|
|
Informed consent - A new approach to drug regulation?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CANNABIS;
ILLICIT DRUG;
NATALIZUMAB;
ROFECOXIB;
SEROTONIN 4 AGONIST;
TEGASEROD;
DRUG;
CANCER;
CLINICAL TRIAL;
CONSTIPATION;
CRIMINAL LAW;
DRUG CONTROL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG SAFETY;
DRUG UTILIZATION;
EDITORIAL;
HEALTH CARE;
HEART INFARCTION;
HUMAN;
INFORMED CONSENT;
ISCHEMIC COLITIS;
MEDICAL ETHICS;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RISK BENEFIT ANALYSIS;
GENETICS;
JURISPRUDENCE;
RISK ASSESSMENT;
GENETICS;
HUMANS;
INFORMED CONSENT;
JURISPRUDENCE;
LEGISLATION, DRUG;
PHARMACEUTICAL PREPARATIONS;
RISK ASSESSMENT;
|
|
EID: 33645236972
PISSN: 02698811
EISSN: 14617285
Source Type: Journal
DOI: 10.1177/0269881106061679 Document Type: Editorial |
|
Times cited : (4)
|
|
References (3)
|
